Interleukin-6 and risk of cognitive decline
Authors:
- 13 August 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 59 (3) , 371-378
Abstract
Objective: To investigate whether plasma interleukin-6 (IL-6) is cross-sectionally related to poorer cognitive function and whether a baseline plasma IL-6 measurement can predict risk for decline in cognitive function in longitudinal follow-up of a population-based sample of nondisabled elderly people. Methods: A prospective cohort study of 779 high-functioning men and women aged 70 to 79 from the MacArthur Study of Successful Aging was conducted. Regression modeling was used to investigate whether baseline IL-6 levels (classified by tertiles) were associated with initial cognitive function and whether IL-6 levels predicted subsequent declines in cognitive function from 1988 to 1991 (2.5-year follow-up) and from 1988 to 1995 (7-year follow-up). Results: Subjects in the highest tertile for plasma IL-6 were marginally more likely to exhibit poorer baseline cognitive function (i.e., scores below the median), independent of demographic status, social status, health and health behaviors, and other physiologic variables (odds ratio [OR] = 1.46; 95% CI: 0.97, 2.20). At 2.5 years, those in both the second tertile of IL-6 (OR = 2.21; 95% CI: 1.44, 3.42) and the third tertile (OR = 2.03; 95% CI: 1.30, 3.19) were at increased risk of cognitive decline even after adjusting for all confounders. At 7 years of follow-up, only those in the highest IL-6 tertile were significantly more likely to exhibit declines in cognition (OR = 1.90; 95% CI: 1.14, 3.18) after adjustment for all confounders. Conclusions: The results suggest a relationship between elevated baseline plasma IL-6 and risk for subsequent decline in cognitive function. These findings are consistent with the hypothesized relationship between brain inflammation, as measured here by elevated plasma IL-6, and neuropathologic disorders.Keywords
This publication has 21 references indexed in Scilit:
- Associations of elevated Interleukin-6 and C-Reactive protein levels with mortality in the elderlyThe American Journal of Medicine, 1999
- Macrophage Colony-stimulating Factor Augments β-Amyloid-induced Interleukin-1, Interleukin-6, and Nitric Oxide Production by Microglial CellsJournal of Biological Chemistry, 1998
- Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brainProceedings of the National Academy of Sciences, 1997
- Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6Neuroscience Letters, 1995
- Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous systemDevelopmental Brain Research, 1994
- Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.Proceedings of the National Academy of Sciences, 1993
- Cognitive Performance in a High-Functioning Community-Dwelling Elderly PopulationJournal of Gerontology, 1993
- Use of Brief Cognitive Tests to Identify Individuals in the Community with Clinically Diagnosed Alzheimer's DiseaseInternational Journal of Neuroscience, 1991
- NMDA receptor antagonists block norepinephrine-induced long-lasting potentiation and long-term potentiation in rat dentate gyrusBrain Research, 1989
- Differential Patterns of Memory Loss Among Patients With Alzheimer's Disease, Huntington's Disease, and Alcoholic Korsakoff's SyndromeArchives of Neurology, 1986